BKYI Stock Overview Develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. More details
Rewards Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
BIO-key International, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for BIO-key International Historical stock prices Current Share Price US$0.87 52 Week High US$4.12 52 Week Low US$0.52 Beta 0.16 1 Month Change -1.14% 3 Month Change -21.62% 1 Year Change -71.75% 3 Year Change -97.92% 5 Year Change -98.77% Change since IPO -99.99%
Recent News & Updates
Third quarter 2024 earnings released: US$0.39 loss per share (vs US$1.26 loss in 3Q 2023) Nov 17
BIO-key International, Inc. Provides Revenues Guidance for the Year 2024 Nov 15
BIO-key International, Inc. to Report Q3, 2024 Results on Nov 14, 2024 Nov 07
Price target decreased by 40% to US$3.00 Aug 16
BIO-key®International, Inc.'s PortalGuard Identity and Access Management Solution and Identity-Bound Biometrics Now Available on the Amazon Web Services Marketplace Aug 15
BIO-key International, Inc. to Report Q2, 2024 Results on Aug 14, 2024 Aug 12 See more updates
Third quarter 2024 earnings released: US$0.39 loss per share (vs US$1.26 loss in 3Q 2023) Nov 17
BIO-key International, Inc. Provides Revenues Guidance for the Year 2024 Nov 15
BIO-key International, Inc. to Report Q3, 2024 Results on Nov 14, 2024 Nov 07
Price target decreased by 40% to US$3.00 Aug 16
BIO-key®International, Inc.'s PortalGuard Identity and Access Management Solution and Identity-Bound Biometrics Now Available on the Amazon Web Services Marketplace Aug 15
BIO-key International, Inc. to Report Q2, 2024 Results on Aug 14, 2024 Aug 12
BIO-key International, Inc., Annual General Meeting, Aug 22, 2024 Jul 11 BIO-key International, Inc. Receives Non-Compliance Letter Regarding Nasdaq Listing Rule 5550(b)(1) BIO-key International, Inc. announced delayed 10-Q filing May 18
BIO-key International, Inc. announced delayed annual 10-K filing Apr 03
BIO-key International, Inc. to Report Q4, 2023 Results on Apr 02, 2024 Mar 28
Forecast to breakeven in 2024 Feb 15 BIO-key International, Inc. announced that it has received $0.547726 million in funding from Dillon Hill Capital, LLC Dec 22
BIO-key International, Inc. announced delayed 10-Q filing Nov 17
BIO-key International, Inc. Announces Resignation of Thomas E. Bush, III From the Board of Directors Nov 15
Price target decreased by 25% to US$1.50 Nov 15 BIO-key International, Inc. has completed a Composite Units Offering in the amount of $3.75025 million. Nov 02
BIO-key International, Inc. announced delayed 10-Q filing Aug 17
Price target decreased by 60% to US$2.00 Aug 16
BIO-key International, Inc. to Report Q2, 2023 Results on Aug 14, 2023 Aug 08
BIO-Key International Receives a Letter from Nasdaq Jul 16
BIO-key Regains Compliance with Nasdaq Rule Requiring Timely Filing of Periodic Financial Reports Following Filing of its First Quarter 2023 Form 10-Q with SEC Jun 14
BIO-key International, Inc., Annual General Meeting, Jul 24, 2023 Jun 10
Bio-Key International, Inc. Appoints Cameron E. Williams to Its Board of Directors Jun 03
BIO-key International Receives Notice of Non-Compliance from Nasdaq May 31
BIO-key International, Inc. announced delayed 10-Q filing May 17
First quarter 2023 earnings released: US$0.057 loss per share (vs US$0.13 loss in 1Q 2022) May 16
BIO-key International, Inc. to Report Q1, 2023 Results on May 15, 2023 May 09
Insufficient new directors May 01
BIO-key International, Inc. Announces Thomas Gilley to Resign from the Board of Directors Feb 18
BIO-key Receives Nasdaq Notification Regarding $1.00 Minimum Closing Bid Price Requirement Jan 16
Bio-Key International, Inc Announces Anticipation of the Planned Retirement of Fred Corsentino, Chief Revenue Officer Jan 04 BIO-key International, Inc. announced that it has received $2.2 million in funding from AJB Investment Management, LLC Dec 24
Price target decreased to US$4.00 Nov 16
Insufficient new directors Nov 16
BIO-Key International, Inc. Provides Revenue Guidance for the Year 2022 Nov 15
BIO-key International, Inc. to Report Q3, 2022 Results on Nov 14, 2022 Nov 08
BIO-key International, Inc. Showcases PortalGuard Identity and Access Management Platform for Higher Education at EDUCAUSE Annual Conference October 25-28 Oct 25 BIO-key International, Inc. Launches Mobile Authenticator with Server-Secured and On-Device Multi-Biometric Methods to Be Showcased At 2022 Gartner IAM Summit Aug 19
BIO-key International, Inc. announced delayed 10-Q filing Aug 17
Insufficient new directors Aug 16
BIO-key International, Inc. Provides Financial Guidance for Full-Year 2022 Aug 13
BIO-key GAAP EPS of -$0.21, revenue of $1.9M Aug 12
BIO-key International, Inc. to Report Q2, 2022 Results on Aug 12, 2022 Aug 06
BIO-key Showcases Biometric Cybersecurity Solutions at MSP Expo Florida (Booth 536) to Support its Growing Distribution Base of Managed Service Providers Jun 22 BIO-key International, Inc. announced delayed 10-Q filing
BIO-key International, Inc. to Report Q1, 2022 Results on May 16, 2022 May 12
BIO-key International, Inc., Annual General Meeting, Jun 24, 2022 May 06 BIO-key International, Inc. announced delayed annual 10-K filing Apr 03
Bio-Key International, Inc. Provides Earnings Guidance for the Full Year 2022 Mar 31
Full year 2021 earnings released: US$0.65 loss per share (vs US$2.08 loss in FY 2020) Mar 30
BIO-key International, Inc. (NasdaqCM:BKYI) signed a definitive agreement to acquire Swivel Secure Europe, S.A. Feb 04
Bio-Key International, Inc. Launches Enhanced Admin Panel and User Experience for IT Teams Managing Its Portalguard Identity-As-A-Service (IDaaS) Solution Dec 16
Insufficient new directors Dec 05
No longer forecast to breakeven Nov 25
Third quarter 2021 earnings released: US$0.13 loss per share (vs US$0.51 loss in 3Q 2020) Nov 18
BIO-key International, Inc Expands Product Line and Market Reach with Launch of FIDO2 Compliant Security Keys in a Variety of Form Factors Sep 29
Forecast to breakeven in 2022 Sep 23
BIO-key International, Inc. Announces Improved Next-Generation EcoID II USB Compact Fingerprint Scanner Aug 24 BIO-Key International, Inc. Confirms Revenue Guidance for the Full Year 2021
Second quarter 2021 earnings released: US$0.15 loss per share (vs US$0.60 loss in 2Q 2020) Aug 18
Bio-Key Introduces SSO Concierge™ to Its Portalguard Identity & Access Management Platform, Eliminating Passwords for Thick Client Applications Jun 23
Here's Why Shareholders May Want To Be Cautious With Increasing BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Pay Packet Jun 12
First quarter 2021 earnings released: US$0.094 loss per share (vs US$1.84 loss in 1Q 2020) May 16
BIO-key International, Inc Provides Earnings Guidance for the Year 2021 May 15
BIO-Key International, Inc. Introduces BIO-key MobileAuth May 11
BIO-key International, Inc. Provides Earnings Guidance for the Fiscal 2021 Mar 27
Full year 2020 earnings released: US$2.08 loss per share (vs US$8.10 loss in FY 2019) Mar 26
BIO-key International, Inc. to Report Fiscal Year 2020 Results on Mar 25, 2021 Mar 18 Shareholder Returns BKYI US Software US Market 7D -9.9% -2.2% -2.4% 1Y -71.8% 21.9% 23.3%
See full shareholder returns
Return vs Industry: BKYI underperformed the US Software industry which returned 21.9% over the past year.
Return vs Market: BKYI underperformed the US Market which returned 23.3% over the past year.
Price Volatility Is BKYI's price volatile compared to industry and market? BKYI volatility BKYI Average Weekly Movement 26.2% Software Industry Average Movement 7.9% Market Average Movement 6.3% 10% most volatile stocks in US Market 16.8% 10% least volatile stocks in US Market 3.1%
Stable Share Price: BKYI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BKYI's weekly volatility (26%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, services and cloud host, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative.
Show more BIO-key International, Inc. Fundamentals Summary How do BIO-key International's earnings and revenue compare to its market cap? BKYI fundamental statistics Market cap US$3.24m Earnings (TTM ) -US$5.29m Revenue (TTM ) US$7.29m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) BKYI income statement (TTM ) Revenue US$7.29m Cost of Revenue US$2.95m Gross Profit US$4.34m Other Expenses US$9.63m Earnings -US$5.29m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -1.42 Gross Margin 59.58% Net Profit Margin -72.53% Debt/Equity Ratio 1,796.8%
How did BKYI perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 02:57 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources BIO-key International, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Jack Vander Aarde Maxim Group
Show 0 more analysts 
